Form SEC STAFF ACTION NUGENEREX IMMUNO-ONCOLOG
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Takeda's Mimrylo for rare blood cancer polycythemia vera
- Moderna prices $2.6B convertible notes offering due 2032
- AiRWA receives Nasdaq deficiency notice over late 10-K filing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
